Cisplatin-induced hyponatremia

被引:0
|
作者
Peyrade, F
Taillan, B
Lebrun, C
Bendini, JC
Passerron, C
Dujardin, P
机构
[1] HOP CIMIEZ,SERV HEMATOL MED INTERNE,F-06003 NICE,FRANCE
[2] HOP LOUIS PASTEUR,GRP NEUROONCOL,F-06002 NICE,FRANCE
来源
PRESSE MEDICALE | 1997年 / 26卷 / 32期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cisplatin is one of the most widely used agents in cancer treatment. Cisplatin regimens can lead to a more or less pronounced hyponatremia in 4 to 10% of cases due to salt wasting with hypomagnesemia and normokaliemia. Functional and renal failure and orthostatic hypotension can be observed. CASE REPORT: A 54-year-old woman with brain metastases of a non-small-cell lung cancer was given a chemotherapy regimen containing cisplatin. Hyponatremia mia with confusion occurred after each cisplatin perfusion. The diagnosis retained was cisplatin-induced salt wasting. The patient was given salt prolonged supplementation and carboplatin was substituted for cisplatin in the chemotherapy regimen. DISCUSSION: Hyponatremia frequently occurs in cancer patients. Cisplatin-induced hyponatremia requires specific management Treatment is based on sodium intake which sometimes takes several months to replete stores. Carboplatin can be used instead of cisplatin in case of major hyponatremia. (C) 1997, Masson, Paris.
引用
收藏
页码:1523 / 1525
页数:3
相关论文
共 50 条
  • [1] CISPLATIN-INDUCED HYPONATREMIA AND RENAL SODIUM WASTING
    ELWESHI, A
    THIEBLEMONT, C
    COTTIN, V
    BARBET, N
    CATIMEL, G
    ACTA ONCOLOGICA, 1995, 34 (02) : 264 - 265
  • [2] Cisplatin-induced hyponatremia and renal sodium wasting
    El, Weshi, A.
    Thieblemont, C.
    Cottin, V.
    Barbet, N.
    Carimel, G.
    Acta Oncologica, 34 (02):
  • [3] Severe Hyponatremia Due to Cisplatin-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone
    Abid, Haisam
    Siddiqui, Nadir
    Gnanajothy, Rosana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (08)
  • [4] Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia - Case report
    Cao, LQ
    Joshi, P
    Sumoza, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 344 - 346
  • [5] Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
    Ochi, Nobuaki
    Yamane, Hiromichi
    Hotta, Katsuyuki
    Fujii, Hiromi
    Isozaki, Hideko
    Honda, Yoshihiro
    Yamagishi, Tomoko
    Kubo, Toshio
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    Takigawa, Nagio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 2401 - 2408
  • [6] Cisplatin-induced nephrotoxicity
    Stewart, J. D.
    Bolt, H. M.
    ARCHIVES OF TOXICOLOGY, 2012, 86 (08) : 1155 - 1156
  • [7] CISPLATIN-INDUCED NEPHROTOXICITY
    MEIJER, S
    SLEIJFER, DT
    MULDER, NH
    DONKER, AJM
    NETHERLANDS JOURNAL OF MEDICINE, 1982, 25 (08): : 262 - 269
  • [8] CISPLATIN-INDUCED BRADYCARDIA
    SCHLAEFFER, F
    TOVI, F
    LEIBERMAN, A
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (12): : 899 - 901
  • [9] CISPLATIN-INDUCED ANEMIA
    VANNGUYEN, B
    JAFFE, N
    LICHTIGER, B
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1121 - 1121
  • [10] Cisplatin-induced nephrotoxicity
    J. D. Stewart
    H. M. Bolt
    Archives of Toxicology, 2012, 86 : 1155 - 1156